Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation

Transplant Proc. 2002 Feb;34(1):97. doi: 10.1016/s0041-1345(01)02683-5.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Factors
  • Antigens, Viral / blood
  • Antilymphocyte Serum / therapeutic use
  • Cytomegalovirus Infections / epidemiology*
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / physiopathology
  • Graft Rejection / epidemiology
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Kidney Transplantation / immunology*
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Mycophenolic Acid / adverse effects*
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Postoperative Complications / epidemiology
  • Postoperative Complications / virology
  • Retrospective Studies
  • Tissue Donors / statistics & numerical data

Substances

  • Antigens, Viral
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Mycophenolic Acid